LianBio Increase (Decrease) in Accounts Payable
LianBio (LIANY) reported Increase (Decrease) in Accounts Payable of $4.95 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2023-11-13
- LianBio increase (decrease) in accounts payable for the quarter ending 2023-09-30 was $4.47M, a 416.51% increase year-over-year.
- LianBio increase (decrease) in accounts payable for the quarter ending 2023-06-30 was -$3.50M.
- LianBio increase (decrease) in accounts payable for the quarter ending 2023-03-31 was $3.98M, a 5.10% increase year-over-year.
- LianBio increase (decrease) in accounts payable for the quarter ending 2022-12-31 was -$614.00K, a 162.53% decline year-over-year.
- LianBio increase (decrease) in accounts payable for fiscal 2022 was -$1.71M.
- LianBio increase (decrease) in accounts payable for fiscal 2021 was -$1.71M, a 141.02% decline from fiscal 2020.
- LianBio increase (decrease) in accounts payable for fiscal 2020 was $4.16M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2023-09-30 | $4.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $973.00K derived: sum of 2 quarters · filed 2023-11-13 | $4.95M 10-Q · filed 2023-11-13 | $4.33M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | -$3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $476.00K 10-Q · filed 2023-08-14 | -$138.00K derived: sum of 3 quarters · filed 2023-08-14 | $728.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $3.98M 10-Q · filed 2023-05-11 | $3.36M derived: sum of 2 quarters · filed 2023-05-11 | $4.23M derived: sum of 3 quarters · filed 2023-11-13 | -$1.51M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | -$614.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $252.00K derived: sum of 2 quarters · filed 2023-11-13 | -$5.49M derived: sum of 3 quarters · filed 2023-11-13 | -$1.71M 10-K · filed 2023-03-28 |
| 2022-09-30 | $866.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$4.87M derived: sum of 2 quarters · filed 2023-11-13 | -$1.09M 10-Q · filed 2023-11-13 | -$109.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$5.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.96M 10-Q · filed 2023-08-14 | -$975.00K derived: sum of 3 quarters · filed 2023-08-14 | -$29.76M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $3.78M 10-Q · filed 2023-05-11 | $4.76M derived: sum of 2 quarters · filed 2023-05-11 | -$24.02M derived: sum of 3 quarters · filed 2023-05-11 | $3.25M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $982.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$27.80M derived: sum of 2 quarters · filed 2023-03-28 | -$537.00K derived: sum of 3 quarters · filed 2023-03-28 | -$1.71M 10-K · filed 2023-03-28 |
| 2021-09-30 | -$28.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.52M derived: sum of 2 quarters · filed 2022-11-10 | -$2.69M 10-Q · filed 2022-11-10 | $1.07M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $27.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $26.09M 10-Q · filed 2022-08-11 | $29.86M derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$1.17M 10-Q · filed 2022-05-12 | $2.59M derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $3.76M derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | $4.16M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $400.00K 10-Q/A · filed 2022-01-10 |